SH3 domains with high affinity and engineered ligand specificities targeted to HIV-1 Nef

Journal of Molecular Biology

Volumn 293, Issue 5, 1999, Pages 1097-1106

  Hiipakka, Marita ^a   Poikonen, Kari ^a   Saksela, Kalle ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Nef; Phage display; PxxP motif; RT loop; SH3

Indexed keywords

ARGININE; GLOBULAR PROTEIN; HEXAPEPTIDE; LIGAND; NEF PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; BACTERIOPHAGE M13; BINDING AFFINITY; DISSOCIATION CONSTANT; GENETIC ENGINEERING; HUMAN IMMUNODEFICIENCY VIRUS 1; LIGAND BINDING; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE HOMOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033550310     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.3225     Document Type: Article

References (38)

1. Arold S., O'Brien R., Franken P., Strub M. P., Hoh F., Dumas C., Ladbury J. E. RT loop flexibility enhances the specificity of src family SH3 domains for HIV-1 Nef. Biochemistry. 37:1998;14683-14691.
2. Atwell S., Ultsch M., De Vos A. M., Wells J. A. Structural plasticity in a remodeled protein-protein interface. Science. 278:1997;1125-1128.
3. Ballinger M. D., Jones J. T., Lofgren J. A., Fairbrother W. J., Akita R. W., Sliwkowski M. X., Wells J. A. Selection of heregulin variants having higher affinity for the ErbB3 receptor by monovalent phage display. J. Biol. Chem. 273:1998;11675-11684.
4. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
5. Cohen G. B., Ren R., Baltimore D. Modular binding domains in signal transduction proteins. Cell. 80:1995;237-248.
6. Dalgarno D. C., Botfield M. C., Rickles R. J. SH3 domains and drug design: ligands, structure, and biological function. Biopolymers. 43:1997;383-400.
7. Dall'Acqua W., Carter P. Antibody engineering. Curr. Opin. Struct. Biol. 8:1998;443-450.
8. Fairbrother W. J., Christinger H. W., Cochran A. G., Fuh G., Keenan C. J., Quan C., Shriver S. K., Tom J. Y., Wells J. A., Cunningham B. C. Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site. Biochemistry. 37:1998;17754-17764.
9. Feng S., Chen J. K., Yu H., Simon J. A., Schreiber S. L. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science. 266:1994;1241-1247.
10. Feng S., Kasahara C., Rickles R. J., Schreiber S. L. Specific interactions outside the proline-rich core of two classes of Src homology 3 ligands. Proc. Natl Acad. Sci. USA. 92:1995;12408-12415.
11. Feng S., Kapoor T. M., Shirai F., Combs A. P., Schreiber S. L. Molecular basis for the binding of SH3 ligands with non-peptide elements identified by combinatorial synthesis. Chem. Biol. 3:1996;661-660.
12. Griffiths A. D., Duncan A. R. Strategies for selection of antibodies by phage display. Curr. Opin. Biotechnol. 9:1998;102-108.
13. Harris M. From negative factor to a critical role in virus pathogenesis: the changing fortunes of Nef. J. Gen. Virol. 77:1996;2379-2392.
14. Jamieson A. C., Kim S. H., Wells J. A. In vitro selection of zinc fingers with altered DNA-binding specificity. Biochemistry. 33:1994;5689-5695.
15. Knudsen B. S., Zheng J., Feller S. M., Mayer J. P., Burrell S. K., Cowburn D., Hanafusa H. Affinity and specificity requirements for the first Src homology 3 domain of the Crk proteins. EMBO J. 14:1995;2191-2198.
16. Lee C. H., Leung B., Lemmon M. A., Zheng J., Cowburn D., Kuriyan J., Saksela K. A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO J. 14:1995;5006-5015.
17. Lee C. H., Saksela K., Mirza U. A., Chait B. T., Kuriyan J. Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell. 85:1996;931-942.
18. Lim W. A. Reading between the lines: SH3 recognition of an intact protein. Structure. 4:1996;657-659.
19. Lim W. A., Richards F. M., Fox R. O. Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains. Nature. 372:1994;375-379.
20. Lowman H. B., Wells J. A. Affinity maturation of human growth hormone by monovalent phage display. J. Mol. Biol. 234:1993;564-578.
21. Manninen A., Hiipakka M., Vihinen M., Lu W., Mayer B. J., Saksela K. SH3-domain binding function of HIV-1 nef is required for association with a PAK-related kinase. Virology. 250:1998;273-282.
22. Mayer B. J., Gupta R. Functions of SH2 and SH3 domains. Curr. Top. Microbiol. Immunol. 228:1998;1-22.
23. Nguyen J. T., Turck C. W., Cohen F. E., Zuckermann R. N., Lim W. A. Exploiting the basis of proline recognition by SH3 and WW domains: design of N-substituted inhibitors. Science. 282:1998;2088-2092.
24. Pawson T., Schlessinger J. SH2 and SH3 domains. Curr. Biol. 3:1993;434-442.
25. Pisabarro M. T., Serrano L. Rational design of specific high-affinity peptide ligands for the Abl- SH3 domain. Biochemistry. 35:1996;10634-10640.
26. Pisabarro M. T., Ortiz A. R., Viguera A. R., Gago F., Serrano L. Molecular modeling of the interaction of polyproline-based peptides with the Abl-SH3 domain: rational modification of the interaction. Protein Eng. 7:1994;1455-1462.
27. Pisabarro M. T., Serrano L., Wilmanns M. Crystal structure of the abl-SH3 domain complexed with a designed high- affinity peptide ligand: implications for SH3-ligand interactions. J. Mol. Biol. 281:1998;513-521.
28. Rickles R. J., Botfield M. C., Weng Z., Taylor J. A., Green O. M., Brugge J. S., Zoller M. J. Identification of Src, Fyn, Lyn, PI3 K and Abl SH3 domain ligands using phage display libraries. EMBO J. 13:1994;5598-5604.
29. Rickles R. J., Botfield M. C., Zhou X. M., Henry P. A., Brugge J. S., Zoller M. J. Phage display selection of ligand residues important for Src homology 3 domain binding specificity. Proc. Natl Acad. Sci. USA. 92:1995;10909-10913.
30. Saksela K. HIV-1 Nef and host cell protein kinases. Front. Biosci. 2:1997;606-618.
31. Saksela K., Cheng G., Baltimore D. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J. 14:1995;484-491.
32. Sparks A. B., Quilliam L. A., Thorn J. M., Der C. J., Kay B. K. Identification and characterization of Src SH3 ligands from phage-displayed random peptide libraries. J. Biol. Chem. 269:1994;23853-23856.
33. Sparks A. B., Rider J. E., Hoffman N. G., Fowlkes D. M., Quillam L. A., Kay B. K. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2. Proc. Natl Acad. Sci. USA. 93:1996;1540-1544.
34. Viguera A. R., Arrondo J. L., Musacchio A., Saraste M., Serrano L. Characterization of the interaction of natural proline-rich peptides with five different SH3 domains. Biochemistry. 33:1994;10925-10933.
35. Weng Z., Rickles R. J., Feng S., Richard S., Shaw A. S., Schreiber S. L., Brugge J. S. Structure-function analysis of SH3 domains: SH3 binding specificity altered by single amino acid substitutions. Mol. Cell. Biol. 15:1995;5627-5634.
36. Wu X., Knudsen B., Feller S. M., Zheng J., Sali A., Cowburn D., Hanafusa H., Kuriyan J. Structural basis for the specific interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk. Structure. 3:1995;215-226.
37. Xu W., Harrison S. C., Eck M. J. Three-dimensional structure of the tyrosine kinase c-Src. Nature. 385:1997;595-602.
38. Yu H., Chen J. K., Feng S., Dalgarno D. C., Brauer A. W., Schreiber S. L. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell. 76:1994;933-945.